BIO-key Q2 revenue up 13% to $1.9M, net loss narrows 51% to $577K; raises $2.5M

BIO KEY INTERNATIONAL INC

Q2 revenue $1.92M, up 13% YoY; license fee revenue up 53% to $1.23M.
Net loss improved to $(577K) or $(0.56)/share vs $(1.17M) or $(2.01)/share in Q2'25; gross margin 87% vs 73%.
Raised $2.5M via warrant exercise at $4.06/share; cash now over $4.5M; reduced 2025 note by $350K to $325K.
1H'26 revenue up 23%, net loss improved 59%; targets profitability in 2H'26.
New wins: Saudi Arabia education, Portugal national security, Central Bank of Jordan, Alabama credit union; completed 1-for-10 reverse split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.